Datasetspublic full text
ClinicalTrials.gov
clinicaltrials · Datasets · License: Public Domain
178,442Documents
1,450Full text
2026-09-30Last indexed
Recent documents from this source
- Effectiveness of Booster With 1 or 2 Doses of HAV Vaccine Among HIV-infected Patients#180220
- Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients#180219
- Phase I Clinical Trial of Recombinant COVID-19 Variant Vaccine (Sf9 Cell) (WSK-V102)#180218
- Safety and Immunogenicity of a Candidate ZIKV Vaccine (ZIKA001)#180217
- Study to Evaluate H56:IC31 in Preventing Rate of TB Recurrence#180216
- Vaccine Effectiveness of a Bivalent RSV Prefusion F Protein-Based Vaccine for Preventing RSV Hospitalizations in Adults#180215
- Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors#180214
- Prevention of RSV Infection in Infants by Administering Nirsevimab to Infants, With or Without Maternal RSV Vaccination#180213
- Text Message Nudges for COVID-19 Vaccination#180212
- The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With mRNA COVID-19 Vaccine.#180211
- A Study to Evaluate the Safety and Immunogenicity of GlaxoSmithKline Biologicals' Influenza Vaccine GSK3206641A Administered in Adults 18 to 64 Years of Age and 65 Years of Age and Older#180210
- Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan.#180209
- Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection#180208
- Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans#180207
- A Placebo-Controlled, Phase I, Pilot Clinical Trial to Evaluate the Safety and Immunogenicity of ENV 2-3, a Yeast-Derived Recombinant Envelope Protein of Human Immunodeficiency Virus-1, in Combination With MTP-PE/MF59 in Individuals With HIV Infection (Placebo Patients Receive MF59 Emulsion Only)#180206
- TPIV200/huFR-1 (A Multi-Epitope Anti-Folate Receptor Vaccine) Plus Anti-PD-L1 MEDI4736 (Durvalumab) in Patients With Platinum Resistant Ovarian Cancer#180205
- Poliovirus Vaccine Trial in Bangladesh#180204
- Post-authorisation Safety Study (PASS) of Influenza Vaccine in United Kingdom (UK)#180203
- EBOVAC-Salone Extension#180202
- DCVAC/OvCa and Standard of Care (SoC) in Relapsed Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma#180201
Source record · clinicaltrials · Datasets · License: Public Domain
Conceptio Open Knowledge Archive — counts are materialised per sync from the index (real full-text coverage, never license entitlement).